Jackson Thornton Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33M Buy
1,413
+45
+3% +$45.6K 0.12% 50
2025
Q4
$1.46M Buy
1,368
+218
+19% +$208K 0.14% 41
2025
Q3
$973K Buy
1,150
+506
+79% +$377K 0.1% 49
2025
Q2
$501K Sell
644
-86
-12% -$66.8K 0.06% 55
2025
Q1
$613K Sell
730
-49
-6% -$40.8K 0.08% 49
2024
Q4
$601K Buy
779
+213
+38% +$176K 0.08% 46
2024
Q3
$501K Sell
566
-1
-0.2% -$899 0.07% 43
2024
Q2
$513K Buy
567
+7
+1% +$5.6K 0.08% 39
2024
Q1
$436K Sell
560
-7
-1% -$4.98K 0.07% 36
2023
Q4
$331K Sell
567
-15
-3% -$8.76K 0.06% 38
2023
Q3
$313K Sell
582
-43
-7% -$22.2K 0.06% 33
2023
Q2
$293K Buy
+625
New +$262K 0.06% 31
2023
Q1
Sell
-1,030
Closed -$377K 37
2022
Q4
$377K Buy
+1,030
New +$365K 0.09% 25
2022
Q3
Sell
-624
Closed -$202K 33
2022
Q2
$202K Buy
+624
New +$187K 0.06% 27

Other funds holding LLY

Jackson Thornton Wealth Management's LLY Position: Q1 2026 in Review

Jackson Thornton Wealth Management increased its Eli Lilly (LLY) stake by 3.3% in Q1 2026, buying an estimated $45.6K and bringing the position to 1,413 shares worth $1.33M. The position accounts for 0.12% of the portfolio, ranked #50.

Jackson Thornton Wealth Management first reported a position in LLY in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.46M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Jackson Thornton Wealth Management held 1,413 shares of Eli Lilly worth $1.33M as of Q1 2026.
  • Jackson Thornton Wealth Management bought 45 Eli Lilly shares in Q1 2026, an estimated $45.6K.
  • Eli Lilly made up 0.12% of Jackson Thornton Wealth Management's portfolio in Q1 2026, its #50 holding.
  • Jackson Thornton Wealth Management first reported a position in Eli Lilly in Q2 2022 and has held it in 14 quarters since.
  • Jackson Thornton Wealth Management's Eli Lilly position peaked at $1.46M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Jackson Thornton Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.